SPP1 and multiple sclerosis: Research in the recent years has found OPN to be upregulated in several neuroinflammatory and neurodegenerative disorders, including multiple sclerosis (MS) [14], Alzheimer’s disease (AD) [15] and age-related macular degeneration (AMD) [16,17,18].